Effects of barbital on neuro-oncogenesis in a transplacental carcinogenicity model using F344 rats.

Effects of barbital (BB) on neuro-oncogenesis were examined in a rat transplacental carcinogenesis model. Pregnant F344 rats were divided into 7 groups. Dams in group I received subcutaneous injections of 10 mg/rat 1-butyl-1-nitrosourea (BNU) on the days 15, 18 and 21 of pregnancy and dams in groups II-IV, 1mg/rat BNU on the same time schedule. In addition to the treatment with BNU, dams in group IV were given 0.125% BB solution as their drinking water from the day 12 of pregnancy to parturition. Offspring in groups III and IV received 0.125% BB solution as drinking water from 4 weeks of age until the termination of the study. Animals in groups V and VI were given 0.25% and 0.125% BB solutions, respectively, in the peri- and postnatal period without BNU treatment. Dams in group VII received 250 mg/kg BB subcutaneously on the days 15, 18 and 21 of pregnancy. Offspring in all groups were observed until 105-116 weeks of age. High yields of neurogenic tumors, such as gliomas and neurinomas, were observed in group I. In groups II, III and IV, single cases of a chordoma, a granular cell tumor, and a neurinoma and a malignant reticulosis, which are known to occur spontaneously, were noted, although no gliomas were found. No neurogenic tumors were observed in groups V-VII. With regard to lesions other than those in neurogenic organs, a significant increase in liver tumors was observed in group III compared to group II. In contrast, lung tumors were not found in group III, while they were observed in groups II and IV. These results suggest that BB has no neuro-carcinogenic activity in the rat transplacental carcinogenesis model.

[1]  K. Mitsumori,et al.  DOSE-DEPENDENT PROMOTING EFFECT OF PHENOBARBITAL ON RAT HEPATOCARCINOGENESIS , 1992 .

[2]  H. Vainio,et al.  Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme. , 1991, Carcinogenesis.

[3]  J. Simpkins,et al.  Distribution of Phenobarbital and Phenytoin in Pregnant Rats and Their Fetuses , 1991, Epilepsia.

[4]  A. Maekawa.  [Characteristics of F344 rats in a stand-point of naturally occurring neoplastic and non-neoplastic lesions]. , 1990, Jikken dobutsu. Experimental animals.

[5]  R. Hiatt,et al.  Exposure to barbiturates in utero and during childhood risk of intracranial and spinal cord tumors. , 1990, Cancer research.

[6]  K. Mitsumori,et al.  Spontaneous occurrence and chemical induction of neurogenic tumors in rats--influence of host factors and specificity of chemical structure. , 1990, Critical reviews in toxicology.

[7]  J. Olsen,et al.  Cancer among epileptic patients exposed to anticonvulsant drugs. , 1989, Journal of the National Cancer Institute.

[8]  J. Swenberg,et al.  Phenobarbital Lacks Promoting Activity for Neurogenic Tumors in F344 Rats Transplacentally Exposed to Ethylnitrosourea , 1989, Journal of neuropathology and experimental neurology.

[9]  B. Diwan,et al.  Effects of postnatal administration of tumour-promoting barbiturates on the development of tumours initiated by prenatal exposure of fetal rats and mice to N-alkylnitrosoureas. , 1989, IARC scientific publications.

[10]  H. Onodera,et al.  Spontaneous Mesotheliomas in Fischer Rats—A Histological and Electron Microscopic Study , 1987, Toxicologic pathology.

[11]  W. Hauser,et al.  Cancer incidence in a cohort of patients with seizure disorders. , 1986, Journal of the National Cancer Institute.

[12]  B. Diwan,et al.  N-Nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital. , 1985, Journal of the National Cancer Institute.

[13]  A. Ito,et al.  Inhibitory effect of phenobarbital on the development of gliomas in WF rats treated neonatally with N-ethyl-N-nitrosourea. , 1985, Journal of the National Cancer Institute.

[14]  J. Ward,et al.  Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium, and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine. , 1985, Journal of the National Cancer Institute.

[15]  M. Takahashi,et al.  Spontaneous tumors of the nervous system and associated organs and/or tissues in rats. , 1984, Gan.

[16]  Joseph K. Haseman,et al.  Use of Historical Control Data in Carcinogenicity Studies in Rodents , 1984, Toxicologic pathology.

[17]  M. Takahashi,et al.  Carcinogenicity of low doses of N-ethyl-N-nitrosourea in F344 rats; a dose-response study. , 1984, Gan.

[18]  S. Fukushima,et al.  Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea. , 1983, Cancer research.

[19]  F. Furukawa,et al.  Spontaneous tumors in F-344/DuCrj rats. , 1983, Gan.

[20]  M. Matsuyama,et al.  Promoting effects of long-term administration of barbital on spontaneous hepatic tumorigenesis in B6C3F1 mice. , 1983, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[21]  J. Ward,et al.  AGE DEPENDENCE OF SUSCEPTIBILITY TO CARCINOGENESIS IN THE NERVOUS SYSTEM , 1982, Annals of the New York Academy of Sciences.

[22]  A. Ito,et al.  Effect of phenobarbital on the development of tumors in mice treated neonatally with N-ethyl-N-nitrosourea. , 1982, Gan.

[23]  N. Konishi,et al.  Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. , 1982, Carcinogenesis.

[24]  G. Williams,et al.  Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions. , 1981, Gan.

[25]  R. Watanabe,et al.  Mechanisms of inhibition by simultaneously administered phenobarbital of 3'-methyl-4-(dimethylamino)azobenzene-induced hepatocarcinogenesis in the rat. , 1980, Gan.

[26]  S. White,et al.  ANTICONVULSANT DRUGS AND CANCER A Cohort Study in Patients with Severe Epilepsy , 1979, The Lancet.

[27]  W. Hauser,et al.  Brain tumors in children exposed to barbiturates. , 1979, Journal of the National Cancer Institute.

[28]  M. Szklo,et al.  Increased risk of brain tumors in children exposed to barbiturates. , 1978, Journal of the National Cancer Institute.

[29]  M. Ishidate,et al.  Chromosome tests with 134 compounds on Chinese hamster cells in vitro--a screening for chemical carcinogens. , 1977, Mutation research.

[30]  L. Santi,et al.  Long‐term administration of ddt or phenobarbital‐na in wistar rats , 1977, International journal of cancer.

[31]  J. Ward,et al.  Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression. , 1975, Journal of the National Cancer Institute.

[32]  A. Maekawa,et al.  Induction of tumors of the nervous system in the ACI/N rat with 1-butyl-1-nitrosourea administered transplacentally, neonatally, or via maternal milk. , 1975, Gan.

[33]  L. Tomatis,et al.  The effect of long-term administration of phenobarbitone in CF-1 mice , 1975 .

[34]  P. Mushlin,et al.  Effects of Dietary Phenobarbital on the Binding of 2-Acetylaminofluorene to Rat Liver Nuclear DNA 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  E. Staffeldt,et al.  Brief communication: Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital. , 1973, Journal of the National Cancer Institute.

[36]  J. Swenberg,et al.  Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats. , 1972, Cancer research.

[37]  Waddell Wj.  Localization and metabolism of drugs in the fetus. , 1972 .

[38]  E. Staffeldt,et al.  Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. , 1971, Cancer research.

[39]  M. Watanabe,et al.  Effect of barbital on carcinogenic action and metabolism of 4-dimethylaminoazobenzene. , 1967, Gan.